by Geoff Botting
Originally published: June 27, 2016
Why adopt diversity? Why should large corporations go out of their way to create a workforce of people from all sorts of backgrounds?
For global pharmaceutical giant GlaxoSmithKline K.K. (GSK), the answer is simple: diversity and inclusion (D&I) policies make perfect business sense.
“I believe that, in a uniform world, there is less chance to have creativity”, explains Philippe Fauchet OBE, the firm’s president and representative director. “I think diversity is a source of potential for any company”.
Diversity breeds innovation, which has never been more critical for business managers. Given the fact that GSK plc has operations in more than 150 countries and is a global leader in the development of a wide range of pharmaceuticals, vaccines and consumer healthcare products, it is a topic close to the heart of the British firm.